These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 20003582)

  • 1. Characteristics of executive function impairment in Parkinson's disease patients without dementia.
    McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
    J Int Neuropsychol Soc; 2010 Mar; 16(2):268-77. PubMed ID: 20003582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive profile of patients with newly diagnosed Parkinson disease.
    Muslimovic D; Post B; Speelman JD; Schmand B
    Neurology; 2005 Oct; 65(8):1239-45. PubMed ID: 16247051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early neuropsychological detection and the characteristics of Parkinson's disease associated with mild dementia.
    Song IU; Kim JS; Jeong DS; Song HJ; Lee KS
    Parkinsonism Relat Disord; 2008 Nov; 14(7):558-62. PubMed ID: 18328767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual dysfunction in Parkinson disease without dementia.
    Uc EY; Rizzo M; Anderson SW; Qian S; Rodnitzky RL; Dawson JD
    Neurology; 2005 Dec; 65(12):1907-13. PubMed ID: 16282276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual tasking, gait rhythmicity, and Parkinson's disease: which aspects of gait are attention demanding?
    Yogev G; Giladi N; Peretz C; Springer S; Simon ES; Hausdorff JM
    Eur J Neurosci; 2005 Sep; 22(5):1248-56. PubMed ID: 16176368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive decline in Parkinson's disease: a prospective longitudinal study.
    Muslimović D; Post B; Speelman JD; De Haan RJ; Schmand B
    J Int Neuropsychol Soc; 2009 May; 15(3):426-37. PubMed ID: 19402929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive changes in Parkinson's disease patients with visual hallucinations.
    Ramirez-Ruiz B; Junque C; Marti MJ; Valldeoriola F; Tolosa E
    Dement Geriatr Cogn Disord; 2007; 23(5):281-8. PubMed ID: 17351320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of Parkinson's disease on sequence learning: perceptual pattern learning and executive function.
    Price A; Shin JC
    Brain Cogn; 2009 Mar; 69(2):252-61. PubMed ID: 18786754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study.
    Hanagasi HA; Gurvit H; Unsalan P; Horozoglu H; Tuncer N; Feyzioglu A; Gunal DI; Yener GG; Cakmur R; Sahin HA; Emre M
    Mov Disord; 2011 Aug; 26(10):1851-8. PubMed ID: 21500280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing mild cognitive impairment in Parkinson's disease.
    Dalrymple-Alford JC; Livingston L; MacAskill MR; Graham C; Melzer TR; Porter RJ; Watts R; Anderson TJ
    Mov Disord; 2011 Mar; 26(4):629-36. PubMed ID: 21287603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment in Parkinson's disease without dementia.
    Rodríguez-Ferreiro J; Cuetos F; Herrera E; Menéndez M; Ribacoba R
    Mov Disord; 2010 Oct; 25(13):2136-41. PubMed ID: 20725913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural assessment of dysexecutive syndrome in Parkinson's disease without dementia: a comparison with other clinical executive tasks.
    Perfetti B; Varanese S; Mercuri P; Mancino E; Saggino A; Onofrj M
    Parkinsonism Relat Disord; 2010 Jan; 16(1):46-50. PubMed ID: 19665420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early cognitive changes and nondementing behavioral abnormalities in Parkinson's disease.
    Levin BE; Katzen HL
    Adv Neurol; 2005; 96():84-94. PubMed ID: 16383214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia.
    Malhi GS; Ivanovski B; Hadzi-Pavlovic D; Mitchell PB; Vieta E; Sachdev P
    Bipolar Disord; 2007; 9(1-2):114-25. PubMed ID: 17391355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficits in visuospatial processing contribute to quantitative measures of freezing of gait in Parkinson's disease.
    Nantel J; McDonald JC; Tan S; Bronte-Stewart H
    Neuroscience; 2012 Sep; 221():151-6. PubMed ID: 22796080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of cognitive dysfunction in Parkinson's disease: a cohort study.
    Verleden S; Vingerhoets G; Santens P
    Eur Neurol; 2007; 58(1):34-40. PubMed ID: 17483583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M; Laatu S; Martikainen K; Marttila R
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memory and executive function impairment predict dementia in Parkinson's disease.
    Levy G; Jacobs DM; Tang MX; Côté LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K
    Mov Disord; 2002 Nov; 17(6):1221-6. PubMed ID: 12465060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.
    Dalaker TO; Larsen JP; Dwyer MG; Aarsland D; Beyer MK; Alves G; Bronnick K; Tysnes OB; Zivadinov R
    Neuroimage; 2009 Oct; 47(4):2083-9. PubMed ID: 19539037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.